Surrozen, Inc. Warrant
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch SRZNW and buy or sell other stocks, ETFs, and their options commission-free!About SRZNW
Surrozen, Inc. is a clinical stage biotechnology company, which engages in the business of discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. The company was founded by K.
CEOCraig C. Parker, MBA
CEOCraig C. Parker, MBA
Employees—
Employees—
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2015
Founded2015
Employees—
Employees—
SRZNW Key Statistics
Market cap—
Market cap—
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume17.54K
Average volume17.54K
High today$0.027
High today$0.027
Low today$0.0201
Low today$0.0201
Open price$0.0201
Open price$0.0201
Volume4.57K
Volume4.57K
52 Week high$1.21
52 Week high$1.21
52 Week low$0.001
52 Week low$0.001
Stock Snapshot
Surrozen, Inc. Warrant(SRZNW) trades at $0.02.
As of 2025-12-12, Surrozen, Inc. Warrant(SRZNW) stock has fluctuated between $0.02 and $0.03. The current price stands at $0.02, placing the stock 0.0% above today's low and -25.6% off the high.
Surrozen, Inc. Warrant(SRZNW) shares are trading with a volume of 4.57K, against a daily average of 17.54K.
During the past year, Surrozen, Inc. Warrant(SRZNW) stock moved between $0.00 at its lowest and $1.21 at its peak.
During the past year, Surrozen, Inc. Warrant(SRZNW) stock moved between $0.00 at its lowest and $1.21 at its peak.